OBIO Announces a Call to Apply for the OBIO Capital Access Advisory Program
SERNOVA PROVIDES CORPORATE UPDATE
Ambu will be distributing Intronix Technologies' Innovative Myoguide™ System Worldwide
Vasomune Therapeutics awarded $1.5 million to advance lead asset for renal disease
Xagenic Appoints Timothy I. Still as President & Chief Executive Officer
Xagenic Announces $6 Million Genome Canada Funded Project in Partnership with University of Toronto